Dutch HTA Calls for Big Discount For Pfizer’s Vyndaqel

Heart
Pfizer's heart failure drug is not cost-effective, says Dutch HTA • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography